<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font22 { font-size : 22; } .font24 { font-size : 24; } .font25 { font-size : 25; } .font27 { font-size : 27; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">resistance </span>
   <span class="font27">viral </span>
   <span class="font25">HIV </span>
   <span class="font24">drug </span>
   <span class="font24">virus </span>
   <span class="font22">mutations </span>
   <span class="font19">hepatitis </span>
   <span class="font19">protease </span>
   <span class="font18">patients </span>
   <span class="font17">human </span>
   <span class="font17">reverse </span>
   <span class="font17">HIV- </span>
   <span class="font17">(.–.) </span>
   <span class="font16">therapy </span>
   <span class="font16">infection </span>
   <span class="font16">inhibitors </span>
   <span class="font16">mutation </span>
   <span class="font16">clinical </span>
   <span class="font16">transcriptase </span>
   <span class="font15">gene </span>
   <span class="font15">type </span>
   <span class="font15">antiretroviral </span>
   <span class="font15">treatment </span>
   <span class="font15">associated </span>
   <span class="font14">drugs </span>
   <span class="font14">genetic </span>
   <span class="font14">load </span>
   <span class="font14">DNA </span>
   <span class="font14">response </span>
   <span class="font14">chronic </span>
   <span class="font14">immunodeficiency </span>
   <span class="font14">viruses </span>
   <span class="font13">lamivudine </span>
   <span class="font13">used </span>
   <span class="font13">cervical </span>
   <span class="font13">cells </span>
   <span class="font13">variants </span>
   <span class="font13">immune </span>
   <span class="font13">analogue </span>
   <span class="font13">antiviral </span>
   <span class="font13">disease </span>
   <span class="font13">development </span>
   <span class="font13">genes </span>
   <span class="font13">variation </span>
   <span class="font12">Med </span>
   <span class="font12">Table </span>
   <span class="font12">analysis </span>
   <span class="font12">studies </span>
   <span class="font12">HPV </span>
   <span class="font12">Viral </span>
   <span class="font12">Virol </span>
   <span class="font12">infected </span>
   <span class="font12">new </span>
   <span class="font12">nucleoside </span>
   <span class="font12">testing </span>
   <span class="font12">therapeutic </span>
   <span class="font12">HCV </span>
   <span class="font12">analogues </span>
   <span class="font12">complex </span>
   <span class="font12">data </span>
   <span class="font12">major </span>
   <span class="font12">sequence </span>
   <span class="font12">{border-style </span>
   <span class="font12">efficacy </span>
   <span class="font12">failure </span>
   <span class="font12">recent </span>
   <span class="font12">(ref) </span>
   <span class="font12">However, </span>
   <span class="font12">active </span>
   <span class="font12">assays </span>
   <span class="font12">cause </span>
   <span class="font12">diseases </span>
   <span class="font12">px;} </span>
   <span class="font12">replication </span>
   <span class="font12">study </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">AIDS </span>
   <span class="font12">HBV </span>
   <span class="font12">Mutations </span>
   <span class="font12">RNA </span>
   <span class="font12">amino </span>
   <span class="font12">different </span>
   <span class="font12">effects </span>
   <span class="font12">host </span>
   <span class="font12">influenza </span>
   <span class="font12">p-trend = . </span>
   <span class="font12">people </span>
   <span class="font12">responses </span>
   <span class="font12">using </span>
   <span class="font12">vaccine </span>
   <span class="font12">SNPs </span>
   <span class="font12">common </span>
   <span class="font12">genome </span>
   <span class="font12">inhibitor </span>
   <span class="font12">polymorphisms </span>
   <span class="font12">role </span>
   <span class="font12">ILB </span>
   <span class="font12">cell </span>
   <span class="font12">combination </span>
   <span class="font12">expression </span>
   <span class="font12">high </span>
   <span class="font12">high-level </span>
   <span class="font12">infections </span>
   <span class="font12">protein </span>
   <span class="font12">selected </span>
   <span class="font12">thymidine </span>
   <span class="font12">various </span>
   <span class="font11">Resistance </span>
   <span class="font11">binding </span>
   <span class="font11">cancer </span>
   <span class="font11">early </span>
   <span class="font11">million </span>
   <span class="font11">target </span>
   <span class="font11">use </span>
   <span class="font11">Hepatitis </span>
   <span class="font11">acid </span>
   <span class="font11">association </span>
   <span class="font11">based </span>
   <span class="font11">individuals </span>
   <span class="font11">pharmacogenomics </span>
   <span class="font11">reported </span>
   <span class="font11">selection </span>
   <span class="font11">significant </span>
   <span class="font11">trial </span>
   <span class="font11">zidovudine </span>
   <span class="font11">Drug </span>
   <span class="font11">activity </span>
   <span class="font11">developed </span>
   <span class="font11">enzyme </span>
   <span class="font11">highly </span>
   <span class="font11">molecular </span>
   <span class="font11">neutralizing </span>
   <span class="font11">polymerase </span>
   <span class="font11">population </span>
   <span class="font11">regimens </span>
   <span class="font11">results </span>
   <span class="font11">susceptibility </span>
   <span class="font11">Engl </span>
   <span class="font11">III </span>
   <span class="font11">adverse </span>
   <span class="font11">agents </span>
   <span class="font11">approach </span>
   <span class="font11">frequently </span>
   <span class="font11">important </span>
   <span class="font11">individual </span>
   <span class="font11">infection. </span>
   <span class="font11">interferon </span>
   <span class="font11">levels </span>
   <span class="font11">multiple </span>
   <span class="font11">mutant </span>
   <span class="font11">persistence </span>
   <span class="font11">prevalence </span>
   <span class="font11">proteins </span>
   <span class="font11">real-time </span>
   <span class="font11">required </span>
   <span class="font11">site </span>
   <span class="font11">strains </span>
   <span class="font11">structure </span>
   <span class="font11">Dis </span>
   <span class="font11">HPV-, </span>
   <span class="font11">In: </span>
   <span class="font11">Infect </span>
   <span class="font11">USA </span>
   <span class="font11">ability </span>
   <span class="font11">antibodies </span>
   <span class="font11">capacity </span>
   <span class="font11">cases </span>
   <span class="font11">class </span>
   <span class="font11">copies/ml </span>
   <span class="font11">database </span>
   <span class="font11">developing </span>
   <span class="font11">domain </span>
   <span class="font11">effect </span>
   <span class="font11">effective </span>
   <span class="font11">emergence </span>
   <span class="font11">include </span>
   <span class="font11">infection, </span>
   <span class="font11">information </span>
   <span class="font11">interaction </span>
   <span class="font11">molecules </span>
   <span class="font11">mutation, </span>
   <span class="font11">mutations, </span>
   <span class="font11">number </span>
   <span class="font11">pathway </span>
   <span class="font11">patient </span>
   <span class="font11">polymorphism </span>
   <span class="font11">primary </span>
   <span class="font11">resistant </span>
   <span class="font11">single </span>
   <span class="font11">specific </span>
   <span class="font11">structural </span>
   <span class="font11">tenofovir </span>
   <span class="font11">types </span>
   <span class="font11">value </span>
   <span class="font11">virologic </span>
   <span class="font11">vs. </span>
   <span class="font11">weeks </span>
   <span class="font11">(Table </span>
   <span class="font11">IFN </span>
   <span class="font11">SNP </span>
   <span class="font11">able </span>
   <span class="font11">additional </span>
   <span class="font11">available </span>
   <span class="font11">caused </span>
   <span class="font11">chain </span>
   <span class="font11">changes </span>
   <span class="font11">containing </span>
   <span class="font11">deaths </span>
   <span class="font11">drug-resistant </span>
   <span class="font11">efavirenz </span>
   <span class="font11">genomic </span>
   <span class="font11">group </span>
   <span class="font11">identified </span>
   <span class="font11">including </span>
   <span class="font11">isolates </span>
   <span class="font11">level </span>
   <span class="font11">located </span>
   <span class="font11">natural </span>
   <span class="font11">occur </span>
   <span class="font11">patients. </span>
   <span class="font11">phenotypic </span>
   <span class="font11">predict </span>
   <span class="font11">presence </span>
   <span class="font11">process </span>
   <span class="font11">progression </span>
   <span class="font11">regimen </span>
   <span class="font11">replicative </span>
   <span class="font11">sequences </span>
   <span class="font11">sequencing </span>
   <span class="font11">sites </span>
   <span class="font11">way </span>
   <span class="font11">HIV-infected </span>
   <span class="font11">Sci </span>
   <span class="font11">T-cell </span>
   <span class="font11">[Abstract </span>
   <span class="font11">approaches </span>
   <span class="font11">assay </span>
   <span class="font11">certain </span>
   <span class="font11">classes </span>
   <span class="font11">combinations </span>
   <span class="font11">core </span>
   <span class="font11">currently </span>
   <span class="font11">detection </span>
   <span class="font11">envelope </span>
   <span class="font11">genotype </span>
   <span class="font11">genotypes </span>
   <span class="font11">genotypic </span>
   <span class="font11">however, </span>
   <span class="font11">identify </span>
   <span class="font11">increase </span>
   <span class="font11">induced </span>
   <span class="font11">involves </span>
   <span class="font11">large </span>
   <span class="font11">likely </span>
   <span class="font11">loss </span>
   <span class="font11">mechanisms </span>
   <span class="font11">nucleotide </span>
   <span class="font11">position </span>
   <span class="font11">potential </span>
   <span class="font11">predictive </span>
   <span class="font11">promoter </span>
   <span class="font11">provide </span>
   <span class="font11">px; </span>
   <span class="font11">rates </span>
   <span class="font11">region </span>
   <span class="font11">result </span>
   <span class="font11">shows </span>
   <span class="font11">small </span>
   <span class="font11">standard </span>
   <span class="font11">substrate </span>
   <span class="font11">targets </span>
   <span class="font11">techniques </span>
   <span class="font11">tests </span>
   <span class="font11">time </span>
   <span class="font11">vaccines </span>
   <span class="font11">virus. </span>
   <span class="font11">vivo </span>
   <span class="font11">wild-type </span>
   <span class="font11">{font-family </span>
   <span class="font10">Diseases </span>
   <span class="font10">Health </span>
   <span class="font10">IFN-lambda </span>
   <span class="font10">Immunol </span>
   <span class="font10">NRTIs </span>
   <span class="font10">Thus, </span>
   <span class="font10">advantage </span>
   <span class="font10">affinity </span>
   <span class="font10">burden </span>
   <span class="font10">catalytic </span>
   <span class="font10">colleagues </span>
   <span class="font10">confer </span>
   <span class="font10">conserved </span>
   <span class="font10">control </span>
   <span class="font10">countries </span>
   <span class="font10">cross-resistance </span>
   <span class="font10">current </span>
   <span class="font10">develop </span>
   <span class="font10">didanosine </span>
   <span class="font10">differences </span>
   <span class="font10">discovery </span>
   <span class="font10">end </span>
   <span class="font10">essential </span>
   <span class="font10">evidence </span>
   <span class="font10">example, </span>
   <span class="font10">font-size </span>
   <span class="font10">generally </span>
   <span class="font10">given </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">higher </span>
   <span class="font10">known </span>
   <span class="font10">limited </span>
   <span class="font10">long-term </span>
   <span class="font10">make </span>
   <span class="font10">mechanism </span>
   <span class="font10">medicine </span>
   <span class="font10">nonnucleoside </span>
   <span class="font10">patterns </span>
   <span class="font10">personalized </span>
   <span class="font10">phenotypes </span>
   <span class="font10">progress </span>
   <span class="font10">protection </span>
   <span class="font10">resistance, </span>
   <span class="font10">ribavirin </span>
   <span class="font10">screening </span>
   <span class="font10">sensitivity </span>
   <span class="font10">showed </span>
   <span class="font10">stavudine </span>
   <span class="font10">trials </span>
   <span class="font10">usually </span>
   <span class="font10">viruses, </span>
   <span class="font10">worldwide, </span>
   <span class="font10">&amp;lt;. </span>
   <span class="font10">(n = ) </span>
   <span class="font10">Acad </span>
   <span class="font10">Clin </span>
   <span class="font10">Genetic </span>
   <span class="font10">HAART </span>
   <span class="font10">IFN-alpha </span>
   <span class="font10">Mutation </span>
   <span class="font10">Natl </span>
   <span class="font10">Pharmacogenomics </span>
   <span class="font10">Protease </span>
   <span class="font10">Rev </span>
   <span class="font10">TAMs </span>
   <span class="font10">Tanaka </span>
   <span class="font10">World </span>
   <span class="font10">acids </span>
   <span class="font10">antibody </span>
   <span class="font10">application </span>
   <span class="font10">codon </span>
   <span class="font10">compared </span>
   <span class="font10">comparison </span>
   <span class="font10">complete </span>
   <span class="font10">conference </span>
   <span class="font10">design </span>
   <span class="font10">diagnosis </span>
   <span class="font10">does </span>
   <span class="font10">double; </span>
   <span class="font10">drugs, </span>
   <span class="font10">escape </span>
   <span class="font10">estimated </span>
   <span class="font10">events </span>
   <span class="font10">evolution </span>
   <span class="font10">field </span>
   <span class="font10">fitness </span>
   <span class="font10">following </span>
   <span class="font10">fusion </span>
   <span class="font10">global </span>
   <span class="font10">health </span>
   <span class="font10">hydrophobic </span>
   <span class="font10">increased </span>
   <span class="font10">infections, </span>
   <span class="font10">interpretation </span>
   <span class="font10">lead </span>
   <span class="font10">leading </span>
   <span class="font10">long </span>
   <span class="font10">low </span>
   <span class="font10">mutants </span>
   <span class="font10">observed </span>
   <span class="font10">possible </span>
   <span class="font10">predicting </span>
   <span class="font10">prediction </span>
   <span class="font10">range </span>
   <span class="font10">recently </span>
   <span class="font10">receptor </span>
   <span class="font10">reduce </span>
   <span class="font10">relatively </span>
   <span class="font10">remain </span>
   <span class="font10">resulting </span>
   <span class="font10">retroviruses </span>
   <span class="font10">risk </span>
   <span class="font10">significantly </span>
   <span class="font10">strategies </span>
   <span class="font10">sustained </span>
   <span class="font10">technology </span>
   <span class="font10">therapy. </span>
   <span class="font10">toxicity </span>
   <span class="font10">treated </span>
   <span class="font10">understanding </span>
   <span class="font10">virological </span>
   <span class="font10">visualization </span>
   <span class="font10">vitro </span>
   <span class="font10">world </span>
   <span class="font10">(%) </span>
   <span class="font10">.). </span>
   <span class="font10">AIDS. </span>
   <span class="font10">America, </span>
   <span class="font10">Cancer </span>
   <span class="font10">DNA. </span>
   <span class="font10">HBs </span>
   <span class="font10">Microbiol </span>
   <span class="font10">NNRTIs </span>
   <span class="font10">Nucleoside </span>
   <span class="font10">PCR </span>
   <span class="font10">RBV </span>
   <span class="font10">San </span>
   <span class="font10">Suppiah </span>
   <span class="font10">Therapy </span>
   <span class="font10">Thomas </span>
   <span class="font10">Web. </span>
   <span class="font10">abacavir </span>
   <span class="font10">accumulation </span>
   <span class="font10">acute </span>
   <span class="font10">addition </span>
   <span class="font10">advanced </span>
   <span class="font10">affect </span>
   <span class="font10">allele </span>
   <span class="font10">alternative </span>
   <span class="font10">amplification </span>
   <span class="font10">associations </span>
   <span class="font10">blood </span>
   <span class="font10">bold </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cancer. </span>
   <span class="font10">candidate </span>
   <span class="font10">candidates </span>
   <span class="font10">carriers </span>
   <span class="font10">cells, </span>
   <span class="font10">cellular </span>
   <span class="font10">change </span>
   <span class="font10">copies/ml. </span>
   <span class="font10">days </span>
   <span class="font10">death </span>
   <span class="font10">described </span>
   <span class="font10">detect </span>
   <span class="font10">determine </span>
   <span class="font10">difference </span>
   <span class="font10">difficult </span>
   <span class="font10">diseases. </span>
   <span class="font10">epitopes </span>
   <span class="font10">functional </span>
   <span class="font10">generation </span>
   <span class="font10">harboring </span>
   <span class="font10">help </span>
   <span class="font10">hepatitis, </span>
   <span class="font10">identification </span>
   <span class="font10">incidence </span>
   <span class="font10">incorporation </span>
   <span class="font10">increases </span>
   <span class="font10">increasing </span>
   <span class="font10">induce </span>
   <span class="font10">infectious </span>
   <span class="font10">inhibit </span>
   <span class="font10">inhibitors, </span>
   <span class="font10">initial </span>
   <span class="font10">involved </span>
   <span class="font10">key </span>
   <span class="font10">knowledge </span>
   <span class="font10">laboratory </span>
   <span class="font10">late </span>
   <span class="font10">like </span>
   <span class="font10">log </span>
   <span class="font10">management </span>
   <span class="font10">methionine </span>
   <span class="font10">model </span>
   <span class="font10">mutation. </span>
   <span class="font10">nevirapine </span>
   <span class="font10">novel </span>
   <span class="font10">opportunistic </span>
   <span class="font10">overall </span>
   <span class="font10">phenotype </span>
   <span class="font10">phenotyping </span>
   <span class="font10">potent </span>
   <span class="font10">precore </span>
   <span class="font10">prevent </span>
   <span class="font10">promote </span>
   <span class="font10">randomized </span>
   <span class="font10">rapid </span>
   <span class="font10">rare </span>
   <span class="font10">rarely </span>
   <span class="font10">reaction </span>
   <span class="font10">reduced </span>
   <span class="font10">related </span>
   <span class="font10">research </span>
   <span class="font10">resistance. </span>
   <span class="font10">responsible </span>
   <span class="font10">sample </span>
   <span class="font10">saquinavir </span>
   <span class="font10">selecting </span>
   <span class="font10">selective </span>
   <span class="font10">short-term </span>
   <span class="font10">solid; </span>
   <span class="font10">stage </span>
   <span class="font10">subjects </span>
   <span class="font10">suggested </span>
   <span class="font10">suppression </span>
   <span class="font10">switch </span>
   <span class="font10">targeted </span>
   <span class="font10">test </span>
   <span class="font10">therapy, </span>
   <span class="font10">transcription </span>
   <span class="font10">understand </span>
   <span class="font10">uses </span>
   <span class="font10">variants. </span>
   <span class="font10">variety </span>
   <span class="font10">versus </span>
   <span class="font10">year </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Carman </span>
   <span class="font10">(Ge </span>
   <span class="font10">(Thio </span>
   <span class="font10">(i) </span>
   <span class="font10">(ii) </span>
   <span class="font10">(iii) </span>
   <span class="font10">Adverse </span>
   <span class="font10">Associated </span>
   <span class="font10">CI, </span>
   <span class="font10">CTL </span>
   <span class="font10">DNA, </span>
   <span class="font10">Dr. </span>
   <span class="font10">Drugs </span>
   <span class="font10">Francisco </span>
   <span class="font10">GWAS </span>
   <span class="font10">Gag </span>
   <span class="font10">Genet </span>
   <span class="font10">Genotype </span>
   <span class="font10">HIV-. </span>
   <span class="font10">HR, </span>
   <span class="font10">Hepatol </span>
   <span class="font10">IL-B </span>
   <span class="font10">Increased </span>
   <span class="font10">Long-term </span>
   <span class="font10">NNRTI </span>
   <span class="font10">NNRTI-experienced </span>
   <span class="font10">Organization </span>
   <span class="font10">Reverse </span>
   <span class="font10">Single </span>
   <span class="font10">Society-USA </span>
   <span class="font10">abacavir, </span>
   <span class="font10">abnormal </span>
   <span class="font10">account </span>
   <span class="font10">achieve </span>
   <span class="font10">adult </span>
   <span class="font10">aim </span>
   <span class="font10">al.Genetic </span>
   <span class="font10">al.Hepatitis </span>
   <span class="font10">alpha </span>
   <span class="font10">analogues, </span>
   <span class="font10">and, </span>
   <span class="font10">antigen </span>
   <span class="font10">appear </span>
   <span class="font10">approximately </span>
   <span class="font10">assess </span>
   <span class="font10">assessment </span>
   <span class="font10">average </span>
   <span class="font10">bNAbs </span>
   <span class="font10">beacon </span>
   <span class="font10">benefit </span>
   <span class="font10">body </span>
   <span class="font10">called </span>
   <span class="font10">central </span>
   <span class="font10">challenges </span>
   <span class="font10">close </span>
   <span class="font10">cohort </span>
   <span class="font10">combined </span>
   <span class="font10">commonly </span>
   <span class="font10">competitive </span>
   <span class="font10">confers </span>
   <span class="font10">contains </span>
   <span class="font10">courier; </span>
   <span class="font10">cytokine </span>
   <span class="font10">daily </span>
   <span class="font10">decreased </span>
   <span class="font10">designed </span>
   <span class="font10">determinant </span>
   <span class="font10">distal </span>
   <span class="font10">distinct </span>
   <span class="font10">drug-metabolizing </span>
   <span class="font10">drugs. </span>
   <span class="font10">effectively </span>
   <span class="font10">em; </span>
   <span class="font10">emerge </span>
   <span class="font10">emerging </span>
   <span class="font10">employed </span>
   <span class="font10">emtricitabine </span>
   <span class="font10">especially </span>
   <span class="font10">example </span>
   <span class="font10">explain </span>
   <span class="font10">fact </span>
   <span class="font10">factor </span>
   <span class="font10">factors </span>
   <span class="font10">findings </span>
   <span class="font10">focused </span>
   <span class="font10">followed </span>
   <span class="font10">form </span>
   <span class="font10">frequency </span>
   <span class="font10">gene. </span>
   <span class="font10">generate </span>
   <span class="font10">genital </span>
   <span class="font10">genomics </span>
   <span class="font10">genotyping </span>
   <span class="font10">half </span>
   <span class="font10">helping </span>
   <span class="font10">hepatocellular </span>
   <span class="font10">humans. </span>
   <span class="font10">identifying </span>
   <span class="font10">incorporated </span>
   <span class="font10">indinavir </span>
   <span class="font10">individual’s </span>
   <span class="font10">induces </span>
   <span class="font10">infectionJ </span>
   <span class="font10">initiation </span>
   <span class="font10">interferons </span>
   <span class="font10">international </span>
   <span class="font10">investigators </span>
   <span class="font10">involving </span>
   <span class="font10">lamivudine, </span>
   <span class="font10">leads </span>
   <span class="font10">led </span>
   <span class="font10">liver </span>
   <span class="font10">longer </span>
   <span class="font10">loop </span>
   <span class="font10">loops </span>
   <span class="font10">lower </span>
   <span class="font10">measure </span>
   <span class="font10">mechanistic </span>
   <span class="font10">minority </span>
   <span class="font10">mortality </span>
   <span class="font10">near </span>
   <span class="font10">necessary </span>
   <span class="font10">negative </span>
   <span class="font10">newer </span>
   <span class="font10">occurring </span>
   <span class="font10">occurs </span>
   <span class="font10">optimal </span>
   <span class="font10">owing </span>
   <span class="font10">pathogenesis </span>
   <span class="font10">patients, </span>
   <span class="font10">patients: </span>
   <span class="font10">performed </span>
   <span class="font10">persistent </span>
   <span class="font10">persons </span>
   <span class="font10">phenomenon </span>
   <span class="font10">platform </span>
   <span class="font10">play </span>
   <span class="font10">pocket </span>
   <span class="font10">power </span>
   <span class="font10">precancer/cancer, </span>
   <span class="font10">predictors </span>
   <span class="font10">present </span>
   <span class="font10">prevention </span>
   <span class="font10">previous </span>
   <span class="font10">primarily </span>
   <span class="font10">probability </span>
   <span class="font10">produce </span>
   <span class="font10">proper </span>
   <span class="font10">protease, </span>
   <span class="font10">providing </span>
   <span class="font10">pt;} </span>
   <span class="font10">qualitative </span>
   <span class="font10">quantitative </span>
   <span class="font10">rash, </span>
   <span class="font10">rate </span>
   <span class="font10">relative </span>
   <span class="font10">removal </span>
   <span class="font10">replication. </span>
   <span class="font10">required, </span>
   <span class="font10">residue </span>
   <span class="font10">respond </span>
   <span class="font10">response. </span>
   <span class="font10">select </span>
   <span class="font10">sequencing, </span>
   <span class="font10">shown </span>
   <span class="font10">signal </span>
   <span class="font10">single-nucleotide </span>
   <span class="font10">specificity </span>
   <span class="font10">strong </span>
   <span class="font10">structures </span>
   <span class="font10">substitution </span>
   <span class="font10">substitutions </span>
   <span class="font10">substrates </span>
   <span class="font10">subtypes </span>
   <span class="font10">suggesting </span>
   <span class="font10">surface </span>
   <span class="font10">synthesis </span>
   <span class="font10">systems </span>
   <span class="font10">taken </span>
   <span class="font10">transcriptase, </span>
   <span class="font10">transmitted </span>
   <span class="font10">values </span>
   <span class="font10">variability </span>
   <span class="font10">virus, </span>
   <span class="font10">wild </span>
   <span class="font10">women </span>
   <span class="font10">work </span>
   <span class="font10">world’s </span>
  </p>
 </body>
</html>
